Clinical Trials Sponsored by Siemens AG

Total 2523 results

Sensimed AG

Completed

SENSIMED Triggerfish Sensor Sizes

Healthy Volunteers

Spain
Sensimed AG

Completed

SENSIMED Triggerfish in Closed Eyes

Glaucoma

Switzerland
Sensimed AG

Completed

Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG

Primary Open Angle Glaucoma | Normal Tension Glaucoma

Poland
Spiraldynamik AG

Completed

Physiotherapy for Chronic Metatarsalgia

Metatarsalgia
Affiris AG

Completed

Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008A)

Parkinson's Disease

Austria
Affiris AG

Terminated

Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006

Alzheimer´s Disease

France, Austria, Croatia, Czech Republic, Germany, Slovakia
Aesculap AG

Completed

Trial to Evaluate the Hemostatic Effect of Lyostypt® Versus Surgicel® in Arterial Bypass Anastomosis (COBBANA)

Peripheral Vascular Diseases | Hemostasis

Germany
4SC AG

Completed

Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)

Advanced Hematologic Malignancies

Germany
Brahms AG

Completed

Procalcitonin Monitoring Sepsis Study (MOSES)

Septic Shock | Severe Sepsis

United States
Eucatech AG

Unknown

Multicentric Non-randomized Investigation of RESISTANT Camouflage Stent-system (RECAM)

Peripheral Artery Disease

Germany, Italy
Biotronik AG

Completed

BIOLUX P-I First in Man Study

Arteriosclerosis | Atherosclerosis | Peripheral Artery Disease | Vascular Disease

Germany, Austria
Biotronik AG

Completed

BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries (BIOLUX P-II)

Arteriosclerosis | Atherosclerosis | Peripheral Artery Disease | Vascular Disease

Belgium, Austria, Germany
Aesculap AG

Completed

Benefit of Orthopedic Navigation in the ARThroplasty of the Hip (BONARTH)

Arthritis, Rheumatoid | Femur Head Necrosis | Osteoarthritis, Hip

Germany
Sensimed AG

Completed

24-hour IOP Pattern With SENSIMED Triggerfish® in a Healthy Population

Healthy Subject

Israel
Devirex AG

Terminated

A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes

Genital Herpes

Switzerland
Mologen AG

Completed

A Phase I Study to Assess Cardiac and General Safety and Pharmacokinetics of 60 mg MGN1703

Healthy

United States
Sensimed AG

Withdrawn

IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy

Primary Open Angle Glaucoma

France
Sensimed AG

Withdrawn

IOP Pattern in Primary Angle Closure and Primary Angle Closure Glaucoma Patients, Before and After LPI

Glaucoma

France
Bitop AG

Completed

Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray

Allergic Rhinitis
Bitop AG

Completed

Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis

Allergic Rhinoconjunctivitis

Germany
Sensimed AG

Completed

Efficacy of 24-hour Intraocular Pressure Fluctuation Recording With the SENSIMED Triggerfish Contact Lens Sensor

Primary Open Angle Glaucoma | Healthy Subjects

United States
4SC AG

Completed

4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma (Shelter)

Hepatocellular Carcinoma

Germany, Italy
Affiris AG

Completed

Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease

Alzheimer's Disease

France, Austria, Croatia, Germany, Czech Republic, Slovakia
Sensimed AG

Completed

SENSIMED Triggerfish Safety and Tolerability

Glaucoma

United States
Aesculap AG

Completed

Dynamic Internal Fixation of Femoral Neck Fractures (DIFINE)

Femoral Neck Fracture

Germany
Biotronik AG

Completed

Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis (PEPPER)

In-stent Coronary Artery Restenosis

Germany
Biomay AG

Completed

Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy

Grass Pollen Allergy

Austria
Affiris AG

Completed

Safety, Immunogenicity and Dose Response of ATH03, a New Vaccine Against the Cholesterol Ester Transfer Protein (CETP)

HDL | Drug Safety

Austria
Sensimed AG

Completed

SENSIMED Triggerfish

Glaucoma

Spain, Belgium, Switzerland, Denmark
Bitop AG

Completed

Efficacy and Feasibility of Ectoin® Inhalation Solution in Inflammatory Obstruction and Ageing of the Lung (EFECT)

COPD | Particulate Matter Induced Inflammation of the Lung

Germany
Affiris AG

Completed

Safety and Tolerability of AFFITOPE AD03 (MimoVax)

Alzheimer's Disease

Austria
NovaShunt AG

Completed

The Automated Fluid Shunt (AFS)in Chronic Congestive Heart Failure

Ascites | Congestive Heart Failure

Sweden
Bitop AG

Completed

Effect of Ectoin® Inhalation Solution on Subjects With Mild Bronchial Asthma

Asthma

Germany
Sensimed AG

Terminated

Water Drinking Test During Intraocular Pressure Fluctuation (IOP) Monitoring

Healthy Subjects

Switzerland
Bitop AG

Completed

Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Germany
4SC AG

Completed

Single Dose Study With 4SC-203 in Healthy Volunteers

Acute Myeloid Leukemia

Germany
ESBATech AG

Completed

Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee

Osteoarthritis

Germany, Switzerland
WaveLight AG

Completed

Comparison of WaveLight Analyzer and Alcon LadarWave

Healthy | Keratoconus

Germany
Affiris AG

Completed

Long-term Safety and Tolerability of AFFITOPE AD02

Alzheimer's Disease

Austria
Idiag AG

Completed

Respiratory Muscle Training in Obstructive Sleep Apnea Syndrome (OSAS) Patients

Obstructive Sleep Apnea Syndrome

Germany
Sensimed AG

Completed

SENSIMED Triggerfish Discomfort During IOP Monitoring (09/02)

Safety and Tolerability of SENSIMED Triggerfish in Glaucoma Patients

Germany
IDEA AG

Completed

IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA

Osteoarthritis; Knee
IDEA AG

Completed

Ketoprofen in Transfersome Compared to Oral Celecoxib and Placebo for Pain Associated With Osteoarthritis of the Knee

Osteoarthritis, Knee
IDEA AG

Completed

Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness

Muscle Soreness

Germany
IDEA AG

Completed

An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee

Osteoarthritis, Knee

United States
IDEA AG

Completed

A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee

Osteoarthritis, Knee

United States
Brahms AG

Completed

Biomarkers in Acute Heart Failure (BACH)

Heart Failure | Shortness of Breath

United States, Poland, Switzerland, New Zealand, Germany, Greece, Italy, United Kingdom
Arpida AG

Completed

Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)

Complicated Skin and Skin Structure Infection

United States
Arpida AG

Completed

Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)

Skin Diseases, Bacterial

United States
SpineSave AG

Not yet recruiting

Mid- or High-flex Rods Versus Low-flex Rods of SpineShape System IV for Treatment of Degenerative Lumbar Spine Diseases

Spondylarthritis | Instability Lumbar Spine | Degenerative Spondylolisthesis | Degenerative Lumbar Spinal Stenosis | Discopathy | Facet Joint Arthrosis

3

Subscribe